108. Efficacy of Dalbavancin Compared to Standard of Care for the Treatment of Osteomyelitis: A Retrospective Study

BACKGROUND: Preliminary data suggest that the efficacy of dalbavancin, a long-acting lipoglycopeptide, may be similar to current standard of care (SoC) treatment options for osteomyelitis, and may be associated with fewer treatment related adverse events. This study assessed the incidence of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Cain, Alexander, Bremmer, Derek N, Carr, Dustin R, Buchanan, Carley, Jacobs, Max, Walsh, Thomas L, Moffa, Matthew, Shively, Nathan, Trienski, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644849/
http://dx.doi.org/10.1093/ofid/ofab466.108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644849/
http://dx.doi.org/10.1093/ofid/ofab466.108

Ejemplares similares